blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2627319

EP2627319 - PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.09.2019
Database last updated on 30.04.2025
FormerThe patent has been granted
Status updated on  19.10.2018
FormerGrant of patent is intended
Status updated on  05.10.2018
FormerExamination is in progress
Status updated on  05.09.2018
FormerGrant of patent is intended
Status updated on  30.04.2018
FormerExamination is in progress
Status updated on  06.12.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2013/34]
Inventor(s)01 / WEN, Hong
11505 Alcinda Lane
North Potomac Maryland 20878 / US
02 / KUMARAPERUMAL, Natrajan
40-B, Byrne Court
Wayne New Jersey 07470 / US
03 / NAUSE, Richard
Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover
New Jersey 07936-1080 / US
 [2013/34]
Representative(s)Larbig, Karen Dorothee, et al
Novartis Pharma AG
Patent Department
4002 Basel / CH
[2013/34]
Application number, filing date11779278.814.10.2011
[2018/47]
WO2011US56275
Priority number, dateUS20100393103P14.10.2010         Original published format: US 393103 P
[2013/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012051488
Date:19.04.2012
Language:EN
[2012/16]
Type: A1 Application with search report 
No.:EP2627319
Date:21.08.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 19.04.2012 takes the place of the publication of the European patent application.
[2013/34]
Type: B1 Patent specification 
No.:EP2627319
Date:21.11.2018
Language:EN
[2018/47]
Search report(s)International search report - published on:EP19.04.2012
ClassificationIPC:A61K9/20, A61K9/28, A61K31/444, A61K47/20, A61K47/26, A61K47/38
[2018/18]
CPC:
A61K9/2054 (EP,US); A61K31/444 (EP,KR,US); A61K47/26 (KR);
A61K47/38 (KR); A61K9/20 (KR); A61K9/2009 (EP,US);
A61K9/2013 (US); A61K9/2018 (US); A61K9/2027 (US);
A61K9/2059 (EP,US); A61K9/2095 (EP,US); A61K9/2813 (US);
A61P17/00 (EP); A61P29/00 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P9/00 (EP) (-)
Former IPC [2013/34]A61K9/20, A61K31/444, A61K47/20, A61K47/26, A61K47/38
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/34]
Extension statesBA14.05.2013
ME14.05.2013
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT EINEM DGAT1-HEMMER[2013/34]
English:PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR[2013/34]
French:COMPOSITIONS PHARMACEUTIQUES CONTENANT UN INHIBITEUR DGAT1[2013/34]
Entry into regional phase14.05.2013National basic fee paid 
14.05.2013Designation fee(s) paid 
14.05.2013Examination fee paid 
Examination procedure14.05.2013Examination requested  [2013/34]
10.12.2013Amendment by applicant (claims and/or description)
20.07.2015Despatch of a communication from the examining division (Time limit: M06)
27.01.2016Reply to a communication from the examining division
03.08.2016Despatch of a communication from the examining division (Time limit: M06)
10.02.2017Reply to a communication from the examining division
30.04.2018Communication of intention to grant the patent
31.08.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
31.08.2018Fee for grant paid
31.08.2018Fee for publishing/printing paid
31.08.2018Receipt of the translation of the claim(s)
04.10.2018Information about intention to grant a patent
04.10.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.07.2015
Opposition(s)22.08.2019No opposition filed within time limit [2019/44]
Fees paidRenewal fee
14.10.2013Renewal fee patent year 03
14.10.2014Renewal fee patent year 04
12.10.2015Renewal fee patent year 05
11.10.2016Renewal fee patent year 06
11.10.2017Renewal fee patent year 07
11.10.2018Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL21.11.2018
CY21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
MK21.11.2018
MT21.11.2018
RS21.11.2018
SM21.11.2018
IS21.03.2019
[2022/31]
Former [2021/34]AL21.11.2018
CY21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
MT21.11.2018
RS21.11.2018
SM21.11.2018
IS21.03.2019
Former [2021/26]AL21.11.2018
CY21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
RS21.11.2018
SM21.11.2018
IS21.03.2019
Former [2020/29]AL21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
RS21.11.2018
SM21.11.2018
IS21.03.2019
Former [2019/37]AL21.11.2018
EE21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
SM21.11.2018
IS21.03.2019
Former [2019/26]AL21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
IS21.03.2019
Former [2019/25]HR21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
IS21.03.2019
Former [2019/23]HR21.11.2018
LT21.11.2018
LV21.11.2018
IS21.03.2019
Former [2019/21]LT21.11.2018
IS21.03.2019
Former [2019/20]LT21.11.2018
Cited inInternational search[XDI]WO2007126957  (NOVARTIS AG [CH], et al)
ExaminationWO2011123401
by applicantWO2007126957
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.